Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05169515
Title A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

follicular lymphoma


Iberdomide + RO7082859

CC-99282 + RO7082859

CC-99282 + Mosunetuzumab

Iberdomide + Mosunetuzumab

Age Groups: senior | adult
Covered Countries ITA | ESP

No variant requirements are available.